Search Results - "Klassen, Preston"

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis by BLOCK, Geoffrey A, KLASSEN, Preston S, LAZARUS, J. Michael, OFSTHUN, Norma, LOWRIE, Edmund G, CHERTOW, Glenn M

“…Mortality rates in ESRD are unacceptably high. Disorders of mineral metabolism (hyperphosphatemia, hypercalcemia, and secondary hyperparathyroidism) are…”
Get full text

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism by Cunningham, John, Danese, Mark, Olson, Kurt, Klassen, Preston, Chertow, Glenn M.

“…Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Secondary…”
Get full text

Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary Hyperparathyroidism by Peacock, Munro, Bilezikian, John P., Klassen, Preston S., Guo, Matthew D., Turner, Stewart A., Shoback, Dolores

“…Calcimimetics increase the sensitivity of parathyroid calcium-sensing receptors to extracellular calcium, thereby reducing PTH secretion. This multicenter,…”
Get full text

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis : A randomized, double-blind, multicenter study by LINDBERG, Jill S, CULLETON, Bruce, ALBIZEM, Moetaz B, COBURN, Jack W, WONG, Gordon, BORAH, Michael F, CLARK, Roderick V, SHAPIRO, Warren B, ROGER, Simon D, HUSSERL, Fred E, KLASSEN, Preston S, GUO, Matthew D

“…Management of secondary hyperparathyroidism is challenging with traditional therapy. The calcimimetic cinacalcet HCl acts on the calcium-sensing receptor to…”
Get full text

Association Between Pulse Pressure and Mortality in Patients Undergoing Maintenance Hemodialysis by Klassen, Preston S, Lowrie, Edmund G, Reddan, Donal N, DeLong, Elizabeth R, Coladonato, Joseph A, Szczech, Lynda A, Lazarus, J. Michael, Owen, Jr, William F

“…CONTEXT Although increased blood pressure is associated with adverse outcomes in the general population, elevated blood pressure is associated with decreased…”
Get full text

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview by Chertow, Glenn M, Pupim, Lara B, Block, Geoffrey A, Correa-Rotter, Ricardo, Drueke, Tilman B, Floege, Jürgen, Goodman, William G, London, Gerard M, Mahaffey, Kenneth W, Moe, Sharon M, Wheeler, David C, Albizem, Moetaz, Olson, Kurt, Klassen, Preston, Parfrey, Patrick

“…The dramatically high rates of mortality and cardiovascular morbidity observed among dialysis patients highlights the importance of identifying and…”
Get full text

Cinacalcet Hydrochloride Is an Effective Treatment for Secondary Hyperparathyroidism in Patients With CKD Not Receiving Dialysis by Charytan, Chaim, Coburn, Jack W., Chonchol, Michel, Herman, James, Lien, Y. Howard, Liu, Wei, Klassen, Preston S., McCary, Laura C., Pichette, Vincent

“…Background: Secondary hyperparathyroidism develops early in patients with chronic kidney disease (CKD). Clinical guidelines from the National Kidney…”
Get full text

Predictors of proteinuria and renal failure among women with HIV infection by Szczech, Lynda Anne, Gange, Stephen J., van der Horst, Charles, Bartlett, John A., Young, Mary, Cohen, Mardge H., Anastos, Kathryn, Klassen, Preston S., Svetkey, Laura P.

“…Predictors of proteinuria and renal failure among women with HIV infection. Glomerular disease with proteinuria and renal failure are complications of human…”
Get full text

Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients by GRIFFITH, Todd F, CHUA, Benjamin S. Y, ALLEN, Andrew S, KLASSEN, Preston S, REDDAN, Donal N, SZCZECH, Lynda A

“…The treatment of hypertension in dialysis patients is prevalent and poorly characterized. beta-Blockers and calcium channel blockers (CCBs) have been…”
Get full text

Trends in anemia management among US hemodialysis patients by COLADONATO, Joseph A, FRANKENFIELD, Diane L, REDDAN, Donal N, KLASSEN, Preston S, SZCZECH, Lynda A, JOHNSON, Curtis A, OWEN, William F

“…This study was undertaken to describe the relationship between hematocrit (Hct) and changes in the prescribed dose of erythropoietin (EPO) as well as selected…”
Get full text

White blood cells as a novel mortality predictor in haemodialysis patients by Reddan, Donal N., Klassen, Preston S., Szczech, Lynda A., Coladonato, Joseph A., O'Shea, Susan, Owen Jr, William F., Lowrie, Edmund G.

“…Background. Many conventional cardiovascular risk factors in the general population are not as predictive in end‐stage renal disease (ESRD). As absolute…”
Get full text

Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients by Szczech, Lynda Anne, Reddan, Donal N., Klassen, Preston S., Coladonato, Joseph, Chua, Benjamin, Lowrie, Edmund G., Lazarus, J. Michael, Owen, William F.

“…Background. Interdialytic weight gain is used as a surrogate for volume expansion in haemodialysis patients and as an indicator of non-compliance. Increased…”
Get full text

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes by HOLLANDER, Priscilla, GUPTA, Alok K, PLODKOWSKI, Raymond, GREENWAY, Frank, BAYS, Harold, BURNS, Colleen, KLASSEN, Preston, FUJIOKA, Ken

“…To assess the efficacy and safety of 32 mg naltrexone sustained-release (SR)/360 mg bupropion SR (NB) in overweight/obese individuals with type 2 diabetes with…”
Get full text

Slowing the progression of diabetic nephropathy and its cardiovascular consequences by McCullough, Peter A., Bakris, George L., Owen, William F., Klassen, Preston S., Califf, Robert M.

“…This paper incorporates the findings from a multidisciplinary meeting on diabetic nephropathy and its renal and cardiovascular complications into a review…”
Get full text

Systolic hypertension: An overview by Griffith, Todd F., Klassen, Preston S., Franklin, Stanley S.

“…[...]we address the challenges of blood pressure control concentrating on risk reduction. 165/<95 mm Hg in men and women aged 30 to 59 years was associated…”
Get full text

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis by Sandborn, William J., Peyrin-Biroulet, Laurent, Zhang, Jinkun, Chiorean, Michael, Vermeire, Séverine, Lee, Scott D., Kühbacher, Tanja, Yacyshyn, Bruce, Cabell, Christopher H., Naik, Snehal U., Klassen, Preston, Panés, Julián

“…Etrasimod (APD334) is an oral, selective sphingosine 1-phosphate receptor modulator in development for immune-mediated inflammatory disorders. We assessed the…”
Get full text

Chronic kidney disease and cardiovascular risk: time to focus on therapy by Reddan, Donal N, Klassen, Preston S

Get full text

Regional variability in anaemia management and haemoglobin in the US by Reddan, Donal N., Frankenfield, Diane L., Klassen, Preston S., Coladonato, Joseph A., Szczech, Lynda, Johnson, Curtis A., Besarab, Anatole, Rocco, Michael, McClellan, William, Wish, Jay, Owen Jr, William F.

“…Background. Regional differences in haemoglobin values and process care measures were examined using data from the Centers for Medicare & Medicaid Services'…”
Get full text

Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial by Torres, Fernando, Farber, Harrison, Ristic, Arsen, McLaughlin, Vallerie, Adams, John, Zhang, Jinkun, Klassen, Preston, Shanahan, William, Grundy, John, Hoffmann, Ines, Cabell, Christopher, Escribano Subías, Pilar, Sood, Namita, Keogh, Anne, D'Souza, Gwyn, Rubin, Lewis

“…This phase 2 study was designed to assess the efficacy, safety and tolerability of immediate-release orally administered ralinepag, a selective, non-prostanoid…”
Get full text

Left ventricular hypertrophy: a surrogate end point or correlate of cardiovascular events in kidney disease? by Griffith, Todd F., Reddan, Donal N., Klassen, Preston S., Owen, William F.

Get full text